NCT04671667 | EA3191 | OPEN
A Phase II Randomized Trial of Adjuvant Therapy with Pembrolizumab after Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma with High Risk Features
NCT04208490 | WF-1805CD | OPEN
Implementation and Effectiveness Trial of HN-STAR
NCT01810913 | RTOG-1216 | OPEN
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
